Mutual of America Capital Management LLC Decreases Stock Position in West Pharmaceutical Services, Inc. (NYSE:WST)

Mutual of America Capital Management LLC trimmed its position in shares of West Pharmaceutical Services, Inc. (NYSE:WST) by 2.7% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 8,954 shares of the medical instruments supplier’s stock after selling 253 shares during the period. Mutual of America Capital Management LLC’s holdings in West Pharmaceutical Services were worth $2,688,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in WST. Ballentine Partners LLC grew its stake in shares of West Pharmaceutical Services by 4.7% during the second quarter. Ballentine Partners LLC now owns 742 shares of the medical instruments supplier’s stock valued at $244,000 after acquiring an additional 33 shares in the last quarter. RFG Advisory LLC grew its stake in West Pharmaceutical Services by 2.3% during the 2nd quarter. RFG Advisory LLC now owns 1,499 shares of the medical instruments supplier’s stock valued at $494,000 after purchasing an additional 34 shares in the last quarter. Covestor Ltd increased its holdings in West Pharmaceutical Services by 14.3% during the 3rd quarter. Covestor Ltd now owns 320 shares of the medical instruments supplier’s stock worth $96,000 after purchasing an additional 40 shares during the last quarter. UMB Bank n.a. raised its position in shares of West Pharmaceutical Services by 1.2% in the 3rd quarter. UMB Bank n.a. now owns 3,941 shares of the medical instruments supplier’s stock valued at $1,183,000 after purchasing an additional 47 shares in the last quarter. Finally, Envestnet Portfolio Solutions Inc. raised its position in shares of West Pharmaceutical Services by 0.4% in the 2nd quarter. Envestnet Portfolio Solutions Inc. now owns 12,554 shares of the medical instruments supplier’s stock valued at $4,135,000 after purchasing an additional 49 shares in the last quarter. Hedge funds and other institutional investors own 93.90% of the company’s stock.

Insider Transactions at West Pharmaceutical Services

In related news, VP Charles Witherspoon sold 703 shares of the firm’s stock in a transaction on Tuesday, October 29th. The stock was sold at an average price of $310.40, for a total transaction of $218,211.20. Following the transaction, the vice president now directly owns 1,253 shares in the company, valued at $388,931.20. This trade represents a 35.94 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Insiders own 0.53% of the company’s stock.

West Pharmaceutical Services Stock Down 1.3 %

WST stock opened at $316.59 on Friday. The company has a current ratio of 3.00, a quick ratio of 2.23 and a debt-to-equity ratio of 0.07. The firm has a 50 day simple moving average of $307.01 and a 200-day simple moving average of $314.28. The company has a market capitalization of $22.93 billion, a P/E ratio of 46.97, a PEG ratio of 24.24 and a beta of 1.00. West Pharmaceutical Services, Inc. has a twelve month low of $265.00 and a twelve month high of $413.70.

West Pharmaceutical Services (NYSE:WST) last announced its quarterly earnings data on Thursday, October 24th. The medical instruments supplier reported $1.85 earnings per share for the quarter, topping the consensus estimate of $1.50 by $0.35. The company had revenue of $746.90 million during the quarter, compared to analyst estimates of $709.62 million. West Pharmaceutical Services had a net margin of 17.37% and a return on equity of 18.41%. The firm’s revenue for the quarter was down .1% compared to the same quarter last year. During the same period last year, the business earned $2.16 EPS. On average, equities research analysts predict that West Pharmaceutical Services, Inc. will post 6.67 earnings per share for the current fiscal year.

West Pharmaceutical Services Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, November 20th. Shareholders of record on Wednesday, November 13th were issued a dividend of $0.21 per share. This represents a $0.84 dividend on an annualized basis and a yield of 0.27%. The ex-dividend date of this dividend was Wednesday, November 13th. This is an increase from West Pharmaceutical Services’s previous quarterly dividend of $0.20. West Pharmaceutical Services’s dividend payout ratio (DPR) is currently 12.46%.

West Pharmaceutical Services Company Profile

West Pharmaceutical Services, Inc designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.